Loading: 100%
Teleflex Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 12,600 (as per Q1 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker TFXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17140175210245280
datesClosing price (adj.)
13.10.2017238.71
11.10.2017239.89
04.10.2017246.08
27.09.2017241.23
20.09.2017236.86
13.09.2017233.97
06.09.2017225.41
30.08.2017207.58
23.08.2017207.63
16.08.2017214.79
09.08.2017210.25
02.08.2017202.67
26.07.2017211.68
19.07.2017211.54
12.07.2017208.36
05.07.2017207.45
27.06.2017205.39
20.06.2017203.18
13.06.2017201.58
06.06.2017203.14
30.05.2017200.42
23.05.2017199.33
16.05.2017193.63
09.05.2017193.40
02.05.2017209.29
25.04.2017200.75
18.04.2017196.24
11.04.2017195.85
04.04.2017191.94
28.03.2017193.88
21.03.2017192.47
14.03.2017193.11
07.03.2017191.14
28.02.2017189.87
21.02.2017183.25
14.02.2017175.67
07.02.2017171.05
31.01.2017166.58
24.01.2017163.40
17.01.2017166.01
10.01.2017166.73
03.01.2017157.77
27.12.2016160.42
19.12.2016159.02
12.12.2016157.36
05.12.2016153.15
28.11.2016149.06
21.11.2016149.35
14.11.2016141.09
07.11.2016144.97
31.10.2016141.81
24.10.2016166.47
17.10.2016167.12
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
238.71n/a
Market Capitalisation
in million USD
10,737n/a
Enterprise Value
in million USD
12,137n/a
Common Shares Outstanding
as per May 1, 2017
44,981,275n/a
Preferred Shares Outstanding
as per May 1, 2017
n/a
Average Basic Shares Outstanding
TTM
44,136,500n/a
Average Diluted Shares Outstanding
TTM
47,104,250n/a
Index Membership
n/a
Business Summary
Teleflex Inc designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 689n/a
Receivables 283n/a
Total Current Assets 1,395n/a
PP&E 355n/a
Total Assets 5,232n/a
Accounts Payable 82n/a
Current Debt 131n/a
Total Current Liabilities 392n/a
Long-Term Debt 1,958n/a
Total Liabilities 3,014n/a
Total Equity 2,219n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 50.27n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 4.75n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.21n/a
Other Ratios
Current Ratio 355.6%n/a
Liabilities to Equity Ratio 135.8%n/a
Debt to Assets Ratio 39.9%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,912
1,435
1,398
1,493
1,551
1,696
1,840
1,810
1,868
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-1,111
-749
-719
-784
-803
-857
-897
-865
-872
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
802
686
679
709
748
839
942
944
996
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-535
-425
-446
-473
-511
-567
-640
-621
-622
Selling, General & Administrative
-503
-388
-404
-424
-454
-502
-579
-569
-563
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-33
-37
-42
-49
-56
-65
-61
-52
-59
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
266
261
233
236
237
272
303
323
374
Non-Operating Income (Loss)
-119
-87
-79
-69
-68
-56
-65
-61
-54
Interest Expense, net
-119
-87
-79
-69
-68
-56
-65
-61
-54
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
147
174
154
167
169
215
238
263
320
Abnormal Gains (Losses)
-27
-10
-49
-22
-335
-40
-18
-18
-74
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
120
164
105
145
-165
176
220
245
246
Income Tax (Expense) Benefit, net
-38
-37
-17
-26
-16
-24
-29
-8
-8
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
82
127
88
119
-182
152
191
237
238
Net Extraordinary Gains (Losses)
-79
-379
-222
-379
11
4
4
12
2
Discontinued Operations
-79
-379
-222
-379
11
4
4
12
2
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
2
-253
-135
-260
-171
156
196
249
240
Minority Interest
-35
-11
-1
-2
-1
-1
-1
-1
0
Net Income
-32
-264
-136
-261
-172
155
194
248
239
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-32
-264
-136
-261
-172
155
194
248
239
Remarks
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 22, 2013 n/a
calculated values,
restated on Feb 24, 2014 n/a
calculated values,
restated on Feb 20, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
188
208
584
337
432
303
338
544
Cash & Cash Equivalents
n/a
188
208
584
337
432
303
338
544
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
265
294
286
298
295
274
262
272
Accounts Receivable, Net
n/a
265
294
286
298
295
274
262
272
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
361
339
299
323
334
336
330
316
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
189
80
111
115
140
83
73
51
Prepaid Expenses
n/a
123
33
62
56
76
76
66
49
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
9
8
8
8
10
7
7
3
Deferred Tax Assets
n/a
58
39
41
51
53
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
1,004
921
1,280
1,073
1,201
996
1,004
1,183
Property, Plant & Equipment, Net
n/a
317
288
252
298
326
317
316
303
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
2,518
2,434
2,392
2,363
2,683
2,609
2,552
2,405
Intangible Assets
n/a
972
919
880
1,059
1,256
1,217
1,200
1,092
Goodwill
n/a
1,459
1,442
1,439
1,238
1,354
1,324
1,296
1,277
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
1
1
4
2
2
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
12
5
2
2
2
1
0
0
Miscellaneous Long Term Assets
n/a
74
68
71
62
70
64
54
35
Total Noncurrent Assets
n/a
2,835
2,722
2,644
2,660
3,008
2,927
2,868
2,708
Total Assets
n/a
3,839
3,643
3,924
3,734
4,209
3,923
3,872
3,891
Liabilities and owners' equity
Payables & Accruals
n/a
316 316390000
268 268473000
238 237729000
241 241128000
252 252471000
245 244862000
231 230519000
236 235586000
Accounts Payable
n/a
95 94983000
85 84846000
67 67092000
75 75165000
72 71967000
64 64100000
66 66305000
69 69400000
Accrued Taxes
n/a
31 30695000
5 4886000
21 21084000
17 16895000
24 23821000
14 13768000
8 8059000
8 7908000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
191 190712000
179 178741000
150 149553000
149 149068000
157 156683000
167 166994000
156 156155000
158 158278000
Short Term Debt
n/a
4 4008000
104 103711000
5 4986000
5 4700000
356 356287000
368 368401000
417 417350000
183 183071000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
17 16709000
49 48579000
28 28292000
29 29472000
26 26362000
20 19506000
16 16251000
9 8989000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
4 4433000
1 1050000
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
17 16709000
44 44146000
27 27242000
29 29472000
26 26362000
20 19506000
16 16251000
9 8989000
Total Current Liabilities
n/a
337 337107000
421 420763000
271 271007000
275 275300000
635 635120000
633 632769000
664 664120000
428 427646000
Long Term Debt
n/a
1,192 1192491000
813 813409000
955 954809000
965 965280000
930 930000000
700 700000000
642 641850000
852 852076000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
724 724333000
622 621705000
716 715504000
712 711570000
2,424 2424142000
676 676319000
555 554711000
476 475798000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
165 164726000
142 141769000
195 194984000
171 170946000
109 109498000
167 167241000
149 149441000
133 133062000
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
399 398923000
371 370819000
421 420833000
419 418874000
515 514715000
399 399203000
316 315983000
271 271377000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
161 160684000
109 109117000
100 99687000
122 121750000
1,800 1799929000
110 109875000
89 89287000
71 71359000
Total Noncurrent Liabilities
n/a
1,917 1916824000
1,435 1435114000
1,670 1670313000
1,677 1676850000
3,354 3354142000
1,376 1376319000
1,197 1196561000
1,328 1327874000
Total Liabilities
n/a
2,254 2253931000
1,856 1855877000
1,941 1941320000
1,952 1952150000
3,989 3989262000
2,009 2009088000
1,861 1860681000
1,756 1755520000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
319 319083000
391 391401000
424 423888000
437 437486000
453 452581000
466 465814000
484 483644000
0 0
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-137 -136600000
-135 -135058000
-131 -131053000
-128 -127948000
-125 -124623000
-121 -121455000
-119 -119424000
0 0
Retained Earnings
n/a
1,432 1431878000
1,579 1578913000
1,847 1847106000
1,601 1601460000
1,696 1696424000
1,828 1827845000
2,016 2016176000
0 0
Other Equity
n/a
-34 -34120000
-52 -51880000
-159 -159353000
-132 -132048000
-111 -110855000
-261 -260895000
-371 -371124000
0 0
Equity Before Minority Interest
n/a
1,580 1580241000
1,783 1783376000
1,981 1980588000
1,779 1778950000
1,914 1913527000
1,911 1911309000
2,009 2009272000
2,138 2137517000
Minority Interest
n/a
5 4833000
4 3902000
2 2195000
3 2587000
2 2489000
2 2390000
2 1821000
0 0
Total Equity
n/a
1,585 1585074000
1,787 1787278000
1,983 1982783000
1,782 1781537000
1,916 1916016000
1,914 1913699000
2,011 2011093000
2,138 2137517000
Total Liabilities & Equity
n/a
3,839 3839005000
3,643 3643155000
3,924 3924103000
3,734 3733687000
5,905 5905278000
3,923 3922787000
3,872 3871774000
3,893 3893037000
Remarks restated on n/a restated on Feb 25, 2011 n/a restated on Feb 24, 2012 n/a restated on Feb 22, 2013 n/a restated on Feb 24, 2014 n/a restated on Feb 20, 2015 n/a restated on Feb 25, 2016 n/a restated on Feb 23, 2017 n/a restated on May 4, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
82
127
88
119
-182
152
191
237
238
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
101
90
82
83
80
93
111
108
118
Non-Cash Items
-9
41
65
8
-17
9
7
-17
13
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-90
-138
-91
-116
313
-23
-19
-25
42
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
84
120
144
94
195
231
290
303
411
Change in Fixed Assets & Intangibles
-33
-26
-29
-45
-65
-64
-68
-61
-53
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
8
314
182
376
67
0
5
0
10
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-5
-1
0
-25
-369
-309
-46
-94
-14
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-30
287
152
307
-368
-373
-108
-155
-57
Dividends Paid
-53
-54
-54
-55
-56
-56
-56
-57
-59
Cash From (Repayment of) Debt
-134
-349
-285
29
-18
288
-230
-24
-50
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
0
0
0
0
0
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
7
1
4
15
8
-1
-1
-5
-10
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-181
-402
-335
-11
-66
231
-288
-86
-119
Net Cash Before Disc. Operations and FX
-127
6
-40
390
-239
90
-106
63
235
Change in Cash from Disc. Operations and Other
118
145
129
-6
-20
-7
-7
-5
-4
Net Cash Before FX
-9
150
89
384
-260
83
-113
58
231
Effect of Foreign Exchange Rates
-8
9
-4
-12
2
8
-19
-25
-27
Net Changes in Cash
-16
159
85
373
-257
92
-132
32
203
Remarks
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 22, 2013 n/a
calculated values,
restated on Feb 24, 2014 n/a
calculated values,
restated on Feb 20, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo